Search
Descriptor English: Blastic Plasmacytoid Dendritic Cell Neoplasm
Descriptor Spanish: Neoplasia de Células Dendríticas Plasmocitoides Blásticas
Descriptor Portuguese: Neoplasia da Célula Dendrítica Plasmocitoide Blástica
Descriptor French: Without translation
Entry term(s): Agranular CD4+ CD56+ Hematodermic Neoplasm Tumor
Agranular CD4+ CD56+ Hematodermic Neoplasm-Tumor
Agranular CD4+ Natural Killer Cell Leukemia
BPDCN
BPDCNs
Blastic NK Cell Lymphoma
Blastic NK-Cell Lymphoma
Blastic NK-Cell Lymphomas
Blastic Natural Killer Leukemia
Blastic Natural Killer Lymphoma
CD4+ CD56+ Hematodermic Neoplasm
CD4+-CD56+ Hematodermic Neoplasm
CD4+-CD56+ Hematodermic Neoplasms
Hematodermic Neoplasm, CD4+-CD56+
Hematodermic Neoplasms, CD4+-CD56+
Lymphoma, Blastic NK-Cell
Lymphoma, Monomorphic NK-Cell
Monomorphic NK Cell Lymphoma
Monomorphic NK-Cell Lymphoma
Monomorphic NK-Cell Lymphomas
NK-Cell Lymphoma, Blastic
NK-Cell Lymphoma, Monomorphic
Neoplasm, CD4+-CD56+ Hematodermic
Tree number(s): C04.557.227.001
C04.557.337.001
C04.557.386.001
C04.588.448.001
C04.588.805.175
C15.378.400.001
C17.800.882.001
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000099067
Scope note: A rare and aggressive hematologic malignancy derived from the precursors of PLASMACYTOID DENDRITIC CELLS. Blastic plasmacytoid dendritic cell neoplasms affect bone marrow and blood in addition to the lymph nodes, spleen, central nervous system, and skin.
Allowable Qualifiers: BL blood
BS blood supply
CF cerebrospinal fluid
CH chemistry
CI chemically induced
CL classification
CN congenital
CO complications
DG diagnostic imaging
DH diet therapy
DI diagnosis
DT drug therapy
EC economics
EH ethnology
EM embryology
EN enzymology
EP epidemiology
ET etiology
GE genetics
HI history
IM immunology
ME metabolism
MI microbiology
MO mortality
NU nursing
PA pathology
PC prevention & control
PP physiopathology
PS parasitology
PX psychology
RH rehabilitation
RT radiotherapy
SC secondary
SU surgery
TH therapy
UL ultrastructure
UR urine
VE veterinary
VI virology
Previous Indexing: Hematologic Neoplasms (1998-2024)
Lymphoma, T-Cell (1997-2024)
Skin Neoplasms (1998-2024)
Public MeSH Note: 2025
History Note: 2025
DeCS ID: 60955
Unique ID: D000099067
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2025/01/01
Date of Entry: 2024/08/09
Revision Date: 2024/07/30
Blastic Plasmacytoid Dendritic Cell Neoplasm - Preferred
Concept UI M000767994
Scope note A rare and aggressive hematologic malignancy derived from the precursors of PLASMACYTOID DENDRITIC CELLS. Blastic plasmacytoid dendritic cell neoplasms affect bone marrow and blood in addition to the lymph nodes, spleen, central nervous system, and skin.
Preferred term Blastic Plasmacytoid Dendritic Cell Neoplasm
Entry term(s) Agranular CD4+ CD56+ Hematodermic Neoplasm Tumor
Agranular CD4+ CD56+ Hematodermic Neoplasm-Tumor
Agranular CD4+ Natural Killer Cell Leukemia
BPDCN
BPDCNs
Blastic NK Cell Lymphoma
Blastic NK-Cell Lymphoma
Blastic NK-Cell Lymphomas
Blastic Natural Killer Leukemia
Blastic Natural Killer Lymphoma
CD4+ CD56+ Hematodermic Neoplasm
CD4+-CD56+ Hematodermic Neoplasm
CD4+-CD56+ Hematodermic Neoplasms
Hematodermic Neoplasm, CD4+-CD56+
Hematodermic Neoplasms, CD4+-CD56+
Lymphoma, Blastic NK-Cell
Lymphoma, Monomorphic NK-Cell
Monomorphic NK Cell Lymphoma
Monomorphic NK-Cell Lymphoma
Monomorphic NK-Cell Lymphomas
NK-Cell Lymphoma, Blastic
NK-Cell Lymphoma, Monomorphic
Neoplasm, CD4+-CD56+ Hematodermic



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey